Heart Attack Signal Found for Spiriva in COPD
(MedPage Today) -- The TIOSPIR trial was used to support safety of the mist inhaler version of tiotropium (Spiriva) compared with dry powder, but the pooled data actually showed something else -- a heart attack signal, researchers argued.
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news
More News: Allergy | Allergy & Immunology | Cardiology | Chronic Obstructive Pulmonary | Heart | Heart Attack | Spiriva | Tiotropium